Common Stock, Shares, Outstanding of INTEGRATED BIOPHARMA INC from 30 Jun 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
INTEGRATED BIOPHARMA INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Jun 2011 to 31 Dec 2025.
  • INTEGRATED BIOPHARMA INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 31,094,510, a 2.6% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

INTEGRATED BIOPHARMA INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 31,094,510 +793,790 +2.6% 31 Dec 2025 10-Q 11 Feb 2026 2026 Q2
Q3 2025 31,059,610 +925,100 +3.1% 30 Sep 2025 10-Q 10 Nov 2025 2026 Q1
Q2 2025 31,059,610 +960,000 +3.2% 30 Jun 2025 10-Q 11 Feb 2026 2026 Q2
Q1 2025 30,300,720 +201,110 +0.67% 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 30,300,720 +201,110 +0.67% 31 Dec 2024 10-Q 13 Feb 2025 2025 Q2
Q3 2024 30,134,510 +34,900 +0.12% 30 Sep 2024 10-Q 13 Nov 2024 2025 Q1
Q2 2024 30,099,610 +150,000 +0.5% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q1 2024 30,099,610 +150,000 +0.5% 31 Mar 2024 10-Q 10 May 2024 2024 Q3
Q4 2023 30,099,610 +150,000 +0.5% 31 Dec 2023 10-Q 12 Feb 2024 2024 Q2
Q3 2023 30,099,610 +150,000 +0.5% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q1
Q2 2023 29,949,610 0 0% 30 Jun 2023 10-K 20 Sep 2024 2024 FY
Q1 2023 29,949,610 +116,666 +0.39% 31 Mar 2023 10-Q 11 May 2023 2023 Q3
Q4 2022 29,949,610 +117,666 +0.39% 31 Dec 2022 10-Q 10 Feb 2023 2023 Q2
Q3 2022 29,949,610 +129,333 +0.43% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q1
Q2 2022 29,949,610 +146,333 +0.49% 30 Jun 2022 10-K 15 Sep 2023 2023 FY
Q1 2022 29,832,944 +85,301 +0.29% 31 Mar 2022 10-Q 12 May 2022 2022 Q3
Q4 2021 29,831,944 +151,001 +0.51% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q2
Q3 2021 29,820,277 +174,334 +0.59% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q1
Q2 2021 29,803,277 +157,334 +0.53% 30 Jun 2021 10-K 13 Sep 2022 2022 FY
Q1 2021 29,747,643 +181,700 +0.62% 31 Mar 2021 10-Q 13 May 2021 2021 Q3
Q4 2020 29,680,943 +115,000 +0.39% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q2
Q3 2020 29,645,943 +80,000 +0.27% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q1
Q2 2020 29,645,943 +80,000 +0.27% 30 Jun 2020 10-K 02 Sep 2021 2021 FY
Q1 2020 29,565,943 0 0% 31 Mar 2020 10-Q 13 May 2020 2020 Q3
Q4 2019 29,565,943 0 0% 31 Dec 2019 10-Q 12 Feb 2020 2020 Q2
Q3 2019 29,565,943 +200,000 +0.68% 30 Sep 2019 10-Q 13 Nov 2019 2020 Q1
Q2 2019 29,565,943 +8,430,769 +40% 30 Jun 2019 10-K 23 Sep 2020 2020 FY
Q1 2019 29,565,943 +8,395,869 +40% 31 Mar 2019 10-Q 15 May 2019 2019 Q3
Q4 2018 29,565,943 +8,395,869 +40% 31 Dec 2018 10-Q 13 Feb 2019 2019 Q2
Q3 2018 29,365,943 +8,195,869 +39% 30 Sep 2018 10-Q 09 Nov 2018 2019 Q1
Q2 2018 21,135,174 0 0% 30 Jun 2018 10-K 29 Aug 2019 2019 FY
Q1 2018 21,170,074 +39,900 +0.19% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 21,170,074 +59,900 +0.28% 31 Dec 2017 10-Q 09 Feb 2018 2018 Q2
Q3 2017 21,170,074 +64,900 +0.31% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 21,135,174 +30,000 +0.14% 30 Jun 2017 10-K 12 Sep 2018 2018 FY
Q1 2017 21,130,174 -9,900 -0.05% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 21,110,174 +5,000 +0.02% 31 Dec 2016 10-Q 10 Feb 2017 2017 Q2
Q3 2016 21,105,174 0 0% 30 Sep 2016 10-Q 10 Nov 2016 2017 Q1
Q2 2016 21,105,174 0 0% 30 Jun 2016 10-K 01 Sep 2017 2017 FY
Q1 2016 21,140,074 +34,900 +0.16% 31 Mar 2016 10-Q 13 May 2016 2016 Q3
Q4 2015 21,105,174 -34,900 -0.16% 31 Dec 2015 10-Q 19 Feb 2016 2016 Q2
Q3 2015 21,105,174 0 0% 30 Sep 2015 10-Q 05 Nov 2015 2016 Q1
Q2 2015 21,105,174 0 0% 30 Jun 2015 10-K 02 Sep 2016 2016 FY
Q1 2015 21,105,174 -9,900 -0.05% 31 Mar 2015 10-Q 14 May 2015 2015 Q3
Q4 2014 21,140,074 +25,000 +0.12% 31 Dec 2014 10-Q 17 Feb 2015 2015 Q2
Q3 2014 21,105,174 -9,900 -0.05% 30 Sep 2014 10-Q 07 Nov 2014 2015 Q1
Q2 2014 21,105,174 +25,000 +0.12% 30 Jun 2014 10-K 04 Sep 2015 2015 FY
Q1 2014 21,115,074 0 0% 31 Mar 2014 10-Q 14 May 2014 2014 Q3
Q4 2013 21,115,074 0 0% 31 Dec 2013 10-Q/A 13 Feb 2014 2014 Q2
Q3 2013 21,115,074 0 0% 30 Sep 2013 10-Q 14 Nov 2013 2014 Q1
Q2 2013 21,080,174 0 0% 30 Jun 2013 10-K 08 Sep 2014 2014 FY
Q1 2013 21,115,074 +84,900 +0.4% 31 Mar 2013 10-Q 15 May 2013 2013 Q3
Q4 2012 21,115,074 +134,900 +0.64% 31 Dec 2012 10-Q 19 Feb 2013 2013 Q2
Q3 2012 21,115,074 +184,900 +0.88% 30 Sep 2012 10-Q 19 Nov 2012 2013 Q1
Q2 2012 21,080,174 +200,000 +0.96% 30 Jun 2012 10-K 30 Sep 2013 2013 FY
Q1 2012 21,030,174 31 Mar 2012 10-Q 21 May 2012 2012 Q3
Q4 2011 20,980,174 31 Dec 2011 10-Q 21 Feb 2012 2012 Q2
Q3 2011 20,930,174 30 Sep 2011 10-Q 21 Nov 2011 2012 Q1
Q2 2011 20,880,174 30 Jun 2011 10-K 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.